Advocacy Resources

 
 
Share this
 
 
Monday, July 27, 2015 - 15:48
Persistence of mother-to-child hepatitis B transmission, astronomical rise of hepatitis C cases related to opioid crisis highlight urgency of tackling largest blood-borne communicable epidemics in U.S.
Tuesday, July 14, 2015 - 13:21
Curbing Healthcare Costs, Preventing Outbreaks and Protecting Communities
Wednesday, June 24, 2015 - 12:42
This is a Presidential Advisory Committe on HIV/AIDS (PACHA) and Centers for Disease Control and Prevention (CDC) /Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment (CHAC) resolution requesting the elimination of the ban on federal funding for the support of syringe access.
Thursday, May 28, 2015 - 13:21
NVHR, in partnership with several organizations, submitted a formal request to CMS asking for a Medicare National Coverage Determination process for hepatitis B screening of high risk individuals.
Monday, May 4, 2015 - 12:48
In recognition of National Hepatitis Awareness Month and May 19th National Hepatitis Testing Day, please join Senator Mazie K. Hirono for a briefing on hepatitis B and the elimination of perinatal transmission.
Tuesday, August 19, 2014 - 09:08
NVHR has created a fact sheet about The Viral Hepatitis Testing Act of 2014 (S. 2538). The legislation would authorize $80 million over three years for a comprehensive national system – an enhancement and strengthening of existing public health programs – for surveillance, education, testing, and linkage to care for HBV and HCV, to prevent transmission, morbidity, and mortality from viral hepatitis-related chronic liver disease and liver cancer.
Tuesday, August 19, 2014 - 09:07
NVHR has developed a fact sheet about The Viral Hepatitis Testing Act of 2013 (H.R. 3723). The legislation would authorize $80 million over three years for a comprehensive national system – an enhancement and strengthening of existing public health programs – for surveillance, education, testing, and linkage to care for HBV and HCV, to prevent transmission, morbidity, and mortality from viral hepatitis-related chronic liver disease and liver cancer.
Tuesday, July 29, 2014 - 14:58
People with chronic hepatitis C who are using methadone or buprenorphine to manage opiate addiction can be safely and effectively treated with AbbVie's 3D all-oral direct-acting antiviral regimen plus ribavirin, resulting in a 97% cure rate, according to a report this week at the 20th International AIDS Conference in Melbourne.
Tuesday, July 29, 2014 - 14:56
The hepatitis C virus (HCV) World Community Advisory Board (CAB) grew from an international AIDS activist movement. The objectives of the meeting were threefold: To provide a forum for leading activists to learn about developments in HCV treatment and access barriers; To find common advocacy strategies; and To meet with pharmaceutical companies about their plans for low- and middle-income countries (LMICs).
Tuesday, July 29, 2014 - 14:48
The importance of integrating people who inject drugs into HCV treatment programs. Arguments from a public health and human rights perspective. This document develops core arguments for why it is relevant, feasible, and indeed crucial to include people who inject drugs in national treatment guidelines and programs for chronic HCV infection – from both public health and human rights perspectives.